InvestSMART

Alcidion Group Limited (ASX: ALC) - Announcements

- Current share price for ALC : $0.098

ASX company news and announcements for Alcidion Group Limited (ALC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alcidion Group Limited (ALC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alcidion Group Limited (ALC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alcidion Group Limited (ALC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$132 Alcidion annouces release of Miya Clinic 20 Apr 2017 3:32PM $0.062 $0.098 risen by 58.06%
$132 Alcidion Extend Patient Flow to Katherine Hospital 18 Apr 2017 9:06AM $0.067 $0.098 risen by 46.27%
$132 Alcidion to present at ASX Spotlight Series 18 Apr 2017 9:05AM $0.067 $0.098 risen by 46.27%
$132 Alcidion Appendix 3Y Announcement 13 Apr 2017 4:38PM $0.067 $0.098 risen by 46.27%
$132 Alcidion secure $2.35m contract with Western Hospital 6 Apr 2017 9:04AM $0.071 $0.098 risen by 38.03%
$132 Appendix 4C - quarterly 4 Apr 2017 3:59PM $0.074 $0.098 risen by 32.43%
$132 Correction to Appendix 3B 31 Mar 2017 6:09PM $0.074 $0.098 risen by 32.43%
$132 Sunshine Coast University Hospital goes live with iCVIS 31 Mar 2017 8:25AM $0.072 $0.098 risen by 36.11%
$132 Alcidion Appendix 3Y,3B and Section 708A Notice 22 Mar 2017 3:58PM $0.071 $0.098 risen by 38.03%
$132 Alcidion to Present at TechKnow Invest Roadshow 15 Mar 2017 8:55AM $0.070 $0.098 risen by 40%
$132 Alcidion and Calvary Health Care Collaboration 7 Mar 2017 8:54AM $0.065 $0.098 risen by 50.77%
$132 Alcidion Half Year Report and Appendix 4D 28 Feb 2017 8:23AM $0.068 $0.098 risen by 44.12%
$132 Appendix 4C for Q2 FY17 31 Jan 2017 8:26AM $0.089 $0.098 risen by 10.11%
$132 Allure Capital transaction with major shareholders 23 Dec 2016 3:50PM $0.088 $0.098 risen by 11.36%
$132 Becoming a substantial holder 23 Dec 2016 10:46AM $0.091 $0.098 risen by 7.69%
$132 Alcidion - Investor Relations Research 16 Dec 2016 2:55PM $0.096 $0.098 risen by 2.08%
$132 Alcidion Executive Director Interview With FNN 14 Dec 2016 8:32AM $0.105 $0.098 fallen by 6.67%
$132 Coffs Habour Health Campus goes live with iCVIS 13 Dec 2016 8:32AM $0.100 $0.098 fallen by 2%
$132 Alcidion Change of Share Registry Address 12 Dec 2016 9:41AM $0.105 $0.098 fallen by 6.67%
$132 Change of Director's Interest Notice 6 Dec 2016 8:48AM $0.115 $0.098 fallen by 14.78%
$132 Appendix 3B 6 Dec 2016 8:41AM $0.115 $0.098 fallen by 14.78%
$132 Final Director's Interest Notice 1 Dec 2016 1:34PM $0.130 $0.098 fallen by 24.62%
$132 Alcidion Results of AGM 29 Nov 2016 4:28PM $0.130 $0.098 fallen by 24.62%
$132 Alcidion AGM presentation 29 Nov 2016 9:12AM $0.135 $0.098 fallen by 27.41%
$132 Chairman's Letter 2016 29 Nov 2016 9:11AM $0.135 $0.098 fallen by 27.41%

501 - 525 of 589 results

Page 21 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.